AAAAAA

   
Results: 1-22 |
Results: 22

Authors: HARTMAN NR LEO KU BREWER TG STRONG JM
Citation: Nr. Hartman et al., THE IN-VITRO METABOLISM OF PENCLOMEDINE IN MOUSE, RAT, AND HUMAN SYSTEMS, Drug metabolism and disposition, 26(6), 1998, pp. 513-519

Authors: KAPETANOVIC IM TORCHIN CD THOMPSON CD MILLER TA MCNEILLY PJ MACDONALD TL KUPFERBERG HJ PERHACH JL SOFIA RD STRONG JM
Citation: Im. Kapetanovic et al., POTENTIALLY REACTIVE CYCLIC CARBAMATE METABOLITE OF THE ANTIEPILEPTICDRUG FELBAMATE PRODUCED BY HUMAN LIVER-TISSUE IN-VITRO, Drug metabolism and disposition, 26(11), 1998, pp. 1089-1095

Authors: VANZIJL PCM DAVIS D ELEFF SM MOONEN CTW PARKER RJ STRONG JM
Citation: Pcm. Vanzijl et al., DETERMINATION OF CEREBRAL GLUCOSE-TRANSPORT AND METABOLIC KINETICS BYDYNAMIC MR SPECTROSCOPY, American journal of physiology: endocrinology and metabolism, 36(6), 1997, pp. 1216-1227

Authors: MOODY DE ALBURGES ME PARKER RJ COLLINS JM STRONG JM
Citation: De. Moody et al., THE INVOLVEMENT OF CYTOCHROME-P450-3A4 IN THE N-DEMETHYLATION OF L-ALPHA-ACETYLMETHADOL (LAAM), NORLAAM, AND METHADONE, Drug metabolism and disposition, 25(12), 1997, pp. 1347-1353

Authors: MCNEILLY PJ TORCHIN CD ANDERSON LW KAPETANOVIC IM KUPFERBERG HJ STRONG JM
Citation: Pj. Mcneilly et al., IN-VITRO GLUCURONIDATION OF D-23129, A NEW ANTICONVULSANT, BY HUMAN LIVER-MICROSOMES AND LIVER SLICES, Xenobiotica, 27(5), 1997, pp. 431-441

Authors: LUDDEN LK LUDDEN TM COLLINS JM PENTIKIS HS STRONG JM
Citation: Lk. Ludden et al., EFFECT OF ALBUMIN ON THE ESTIMATION, IN-VITRO, OF PHENYTOIN V-MAX ANDK-M VALUES - IMPLICATIONS FOR CLINICAL CORRELATION, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 391-396

Authors: WAUD WR TIWARI A SCHMID SM SHIH TW STRONG JM HARTMAN NR OREILLY S STRUCK RF
Citation: Wr. Waud et al., 4-DEMETHYLPENCLOMEDINE, AN ANTITUMOR-ACTIVE, POTENTIALLY NONNEUROTOXIC METABOLITE OF PENCLOMEDINE, Cancer research, 57(5), 1997, pp. 815-817

Authors: ANDERSON LW CHEN TL COLVIN OM GROCHOW LB COLLINS JM KENNEDY MJ STRONG JM
Citation: Lw. Anderson et al., CYCLOPHOSPHAMIDE AND 4-HYDROXYCYCLOPHOSPHAMIDE ALDOPHOSPHAMIDE KINETICS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE CHEMOTHERAPY/, Clinical cancer research, 2(9), 1996, pp. 1481-1487

Authors: HARTMAN NR OREILLY S ROWINSKY EK COLLINS JM STRONG JM
Citation: Nr. Hartman et al., MURINE AND HUMAN IN-VIVO PENCLOMEDINE METABOLISM, Clinical cancer research, 2(6), 1996, pp. 953-962

Authors: OREILLY S HARTMAN NR GROSSMAN SA STRONG JM STRUCK RF ELLER S LESSER GJ DONEHOWER RC ROWINSKY EK
Citation: S. Oreilly et al., TISSUE AND TUMOR DISTRIBUTION OF C-14 PENCLOMEDINE IN RATS, Clinical cancer research, 2(3), 1996, pp. 541-548

Authors: TORCHIN CD MCNEILLY PJ KAPETANOVIC IM STRONG JM KUPFERBERG HJ
Citation: Cd. Torchin et al., STEREOSELECTIVE METABOLISM OF A NEW ANTICONVULSANT DRUG CANDIDATE, LOSIGAMONE, BY HUMAN LIVER-MICROSOMES, Drug metabolism and disposition, 24(9), 1996, pp. 1002-1008

Authors: PARKER RJ COLLINS JM STRONG JM
Citation: Rj. Parker et al., IDENTIFICATION OF 2,6-XYLIDINE AS A MAJOR LIDOCAINE METABOLITE IN HUMAN LIVER SLICES, Drug metabolism and disposition, 24(11), 1996, pp. 1167-1173

Authors: LUDDEN LK PENTIKIS HS LUDDEN TM COLLINS JM STRONG JM
Citation: Lk. Ludden et al., THE ADDITION OF ALBUMIN, IN-VITRO, YIELDS MEANINGFUL FREE DRUG KM VALUES FOR PHENYTOIN METABOLISM, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 45-45

Authors: ANDERSON LW LUDEMAN SM COLVIN OM GROCHOW LB STRONG JM
Citation: Lw. Anderson et al., QUANTITATION OF 4-HYDROXYCYCLOPHOSPHAMIDE ALDOPHOSPHAMIDE IN WHOLE-BLOOD, Journal of chromatography B. Biomedical applications, 667(2), 1995, pp. 247-257

Authors: LUDDEN LK STRONG JM KOHN EC COLLINS JM
Citation: Lk. Ludden et al., SIMILARITY OF METABOLISM FOR CAI (NSC-609974) IN HUMAN LIVER-TISSUE IN-VITRO AND IN HUMANS IN-VIVO, Clinical cancer research, 1(4), 1995, pp. 399-405

Authors: LUDEMAN SM SHULMANROSKES EM WONG KKT HAN SY ANDERSON LW STRONG JM COLVIN OM
Citation: Sm. Ludeman et al., OXIME DERIVATIVES OF THE INTERMEDIARY ONCOSTATIC METABOLITES OF CYCLOPHOSPHAMIDE AND IFOSFAMIDE - SYNTHESIS AND DEUTERIUM LABELING FOR APPLICATIONS TO METABOLITE QUANTIFICATION, Journal of pharmaceutical sciences, 84(4), 1995, pp. 393-398

Authors: MCLACHLAN BG BELL JH PARK H KENNELLY RA SCHREINER JA SMITH SC STRONG JM GALLERY J GOUTERMAN M
Citation: Bg. Mclachlan et al., PRESSURE-SENSITIVE PAINT MEASUREMENTS ON A SUPERSONIC HIGH-SWEEP OBLIQUE WING MODEL, Journal of aircraft, 32(2), 1995, pp. 217-227

Authors: STRONG JM MOODY DE PARKER RJ ALBURGES ME COLLINS JM
Citation: Jm. Strong et al., PROTOCOL FOR INVESTIGATING P450 METABOLISM OF L-ALPHA-ACETYLMETHADOL (LAAM) IN HUMAN LIVER-TISSUE IN-VITRO, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 148-148

Authors: PARKER RJ COLLINS JM STRONG JM
Citation: Rj. Parker et al., METABOLISM OF LIDOCAINE IN HUMAN LIVER SLICES AND LIVER-MICROSOMES - IDENTIFICATION OF 2,6-XYLIDINE AS A MAJOR METABOLITE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 211-211

Authors: TAKIMOTO CH KLECKER RW DAHUT WL YEE LK STRONG JM ALLEGRA CJ GREM JL
Citation: Ch. Takimoto et al., ANALYSIS OF THE ACTIVE LACTONE FORM OF 9-AMINOCAMPTOTHECIN IN PLASMA USING SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 655(1), 1994, pp. 97-104

Authors: BYRNE BM RASMUSSEN MJ STRONG JM
Citation: Bm. Byrne et al., EXPENSIVE TRIPLETS - REPLY, Irish medical journal, 86(5), 1993, pp. 171-171

Authors: TAKIMOTO CH VOELLER DB STRONG JM ANDERSON L CHU E ALLEGRA CJ
Citation: Ch. Takimoto et al., EFFECTS OF 5-FLUOROURACIL SUBSTITUTION ON THE RNA CONFORMATION AND IN-VITRO TRANSLATION OF THYMIDYLATE SYNTHASE MESSENGER-RNA, The Journal of biological chemistry, 268(28), 1993, pp. 21438-21442
Risultati: 1-22 |